• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤总体生存的白质束密度指数预测模型。

White Matter Tract Density Index Prediction Model of Overall Survival in Glioblastoma.

机构信息

Clinica Neurologica, Department of Neuroscience, University of Padova, Padova, Italy.

Padova Neuroscience Center, University of Padova, Padova, Italy.

出版信息

JAMA Neurol. 2023 Nov 1;80(11):1222-1231. doi: 10.1001/jamaneurol.2023.3284.

DOI:10.1001/jamaneurol.2023.3284
PMID:37747720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10520843/
Abstract

IMPORTANCE

The prognosis of overall survival (OS) in patients with glioblastoma (GBM) may depend on the underlying structural connectivity of the brain.

OBJECTIVE

To examine the association between white matter tracts affected by GBM and patients' OS by means of a new tract density index (TDI).

DESIGN, SETTING, AND PARTICIPANTS: This prognostic study in patients with a histopathologic diagnosis of GBM examined a discovery cohort of 112 patients who underwent surgery between February 1, 2015, and November 30, 2020 (follow-up to May 31, 2023), in Italy and 70 patients in a replicative cohort (n = 70) who underwent surgery between September 1, 2012, and November 30, 2015 (follow-up to May 31, 2023), in Germany. Statistical analyses were performed from June 1, 2021, to May 31, 2023. Thirteen and 12 patients were excluded from the discovery and the replicative sets, respectively, because of magnetic resonance imaging artifacts.

EXPOSURE

The density of white matter tracts encompassing GBM.

MAIN OUTCOMES AND MEASURES

Correlation, linear regression, Cox proportional hazards regression, Kaplan-Meier, and prediction analysis were used to assess the association between the TDI and OS. Results were compared with common prognostic factors of GBM, including age, performance status, O6-methylguanine-DNA methyltransferase methylation, and extent of surgery.

RESULTS

In the discovery cohort (n = 99; mean [SD] age, 62.2 [11.5] years; 29 female [29.3%]; 70 male [70.7%]), the TDI was significantly correlated with OS (r = -0.34; P < .001). This association was more stable compared with other prognostic factors. The TDI showed a significant regression pattern (Cox: hazard ratio, 0.28 [95% CI, 0.02-0.55; P = .04]; linear: t = -2.366; P = .02). and a significant Kaplan-Meier stratification of patients as having lower or higher OS based on the TDI (log-rank test = 4.52; P = .03). Results were confirmed in the replicative cohort (n = 58; mean [SD] age, 58.5 [11.1] years, 14 female [24.1%]; 44 male [75.9%]). High (24-month cutoff) and low (18-month cutoff) OS was predicted based on the TDI computed in the discovery cohort (accuracy = 87%).

CONCLUSIONS AND RELEVANCE

In this study, GBMs encompassing regions with low white matter tract density were associated with longer OS. These findings indicate that the TDI is a reliable presurgical outcome predictor that may be considered in clinical trials and clinical practice. These findings support a framework in which the outcome of GBM depends on the patient's brain organization.

摘要

背景

胶质母细胞瘤(GBM)患者的总生存(OS)预后可能取决于大脑的基础结构连通性。

目的

通过一种新的白质束密度指数(TDI),研究受 GBM 影响的白质束与患者 OS 之间的关联。

设计、地点和参与者:这项在经组织病理学诊断为 GBM 的患者中进行的预后研究,纳入了意大利 112 名患者的发现队列(2015 年 2 月 1 日至 2020 年 11 月 30 日接受手术,随访至 2023 年 5 月 31 日)和德国的 70 名复制队列患者(n=70,于 2012 年 9 月 1 日至 2015 年 11 月 30 日接受手术,随访至 2023 年 5 月 31 日)。统计分析于 2021 年 6 月 1 日至 2023 年 5 月 31 日进行。由于磁共振成像伪影,分别有 13 名和 12 名患者被排除在发现组和复制组之外。

暴露

GBM 累及的白质束密度。

主要结局和测量指标

采用相关性、线性回归、Cox 比例风险回归、Kaplan-Meier 分析和预测分析来评估 TDI 与 OS 之间的关联。结果与 GBM 的常见预后因素(包括年龄、表现状态、O6-甲基鸟嘌呤-DNA 甲基转移酶甲基化和手术范围)进行了比较。

结果

在发现队列(n=99;平均[SD]年龄 62.2[11.5]岁;女性 29 例[29.3%];男性 70 例[70.7%])中,TDI 与 OS 显著相关(r=-0.34;P<0.001)。与其他预后因素相比,这种关联更加稳定。TDI 显示出显著的回归模式(Cox:危险比,0.28[95%CI,0.02-0.55;P=0.04];线性:t=-2.366;P=0.02),并根据 TDI 对患者进行了显著的 Kaplan-Meier 分层,低或高 OS(对数秩检验=4.52;P=0.03)。结果在复制队列(n=58;平均[SD]年龄 58.5[11.1]岁,女性 14 例[24.1%];男性 44 例[75.9%])中得到了证实。基于在发现队列中计算的 TDI ,对高(24 个月截止值)和低(18 个月截止值)OS 进行了预测(准确性=87%)。

结论和相关性

在这项研究中,GBM 累及白质束密度低的区域与更长的 OS 相关。这些发现表明,TDI 是一种可靠的术前预后预测指标,可在临床试验和临床实践中考虑。这些发现支持了一种框架,即 GBM 的结果取决于患者的大脑组织。

相似文献

1
White Matter Tract Density Index Prediction Model of Overall Survival in Glioblastoma.胶质母细胞瘤总体生存的白质束密度指数预测模型。
JAMA Neurol. 2023 Nov 1;80(11):1222-1231. doi: 10.1001/jamaneurol.2023.3284.
2
Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma.肿瘤相关的白质连接改变在 MGMT 未甲基化的胶质母细胞瘤中具有预后意义。
J Neurooncol. 2022 Jul;158(3):331-339. doi: 10.1007/s11060-022-04018-3. Epub 2022 May 7.
3
Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.辅助治疗后不可切除胶质母细胞瘤中MGMT启动子状态的预后价值
Clin Neurol Neurosurg. 2015 May;132:1-8. doi: 10.1016/j.clineuro.2015.01.029. Epub 2015 Feb 7.
4
MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?胶质母细胞瘤患者 MGMT 启动子甲基化:甲基化敏感高分辨率熔解曲线分析优于甲基化敏感聚合酶链反应检测吗?
J Neurosurg. 2019 Mar 1;130(3):780-788. doi: 10.3171/2017.11.JNS171710. Epub 2018 May 4.
5
White matter tract density index is associated with disability in multiple sclerosis.脑白质束密度指数与多发性硬化症的残疾有关。
Neurobiol Dis. 2024 Aug;198:106548. doi: 10.1016/j.nbd.2024.106548. Epub 2024 May 31.
6
Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.复发性胶质母细胞瘤患者接受挽救性立体定向放射外科治疗的结果和预后分层。
J Neurosurg. 2018 Oct 19;131(2):489-499. doi: 10.3171/2018.4.JNS172909. Print 2019 Aug 1.
7
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.利用影像学、临床和基因组生物标志物预测胶质母细胞瘤患者的预后:重点关注肿瘤的非增强部分。
Radiology. 2014 Aug;272(2):484-93. doi: 10.1148/radiol.14131691. Epub 2014 Mar 19.
8
Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.动脉自旋标记灌注加权成像有助于预测胶质母细胞瘤的分子生物标志物和生存。
Eur Radiol. 2020 Feb;30(2):1202-1211. doi: 10.1007/s00330-019-06379-2. Epub 2019 Aug 29.
9
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.胶质肉瘤与多形性胶质母细胞瘤的临床结局比较:一项针对中国患者的临床研究
J Neurooncol. 2016 Apr;127(2):355-62. doi: 10.1007/s11060-015-2046-0. Epub 2016 Jan 2.
10
Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.基于 MRI 的影像组学预后分类器在原发性多形性胶质母细胞瘤患者中的建立与验证。
Acad Radiol. 2019 Oct;26(10):1292-1300. doi: 10.1016/j.acra.2018.12.016. Epub 2019 Jan 17.

引用本文的文献

1
Deciphering the Potential Causal and Prognostic Relationships Between Gut Microbiota and Brain Tumors: Insights from Genetics Analysis and Machine Learning.解读肠道微生物群与脑肿瘤之间潜在的因果关系和预后关系:来自遗传学分析和机器学习的见解
Exploration (Beijing). 2025 May 1;5(4):e20240087. doi: 10.1002/EXP.20240087. eCollection 2025 Aug.
2
Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma.胶质瘤的解剖分布及预后异质性:枕叶胶质母细胞瘤的独特临床特征
J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05144-4.
3
Spatial Mapping of Glioblastoma Infiltration: Diffusion Tensor Imaging-Based Radiomics and Connectomics in Recurrence Prediction.胶质母细胞瘤浸润的空间映射:基于扩散张量成像的放射组学和连接组学在复发预测中的应用
Brain Sci. 2025 May 27;15(6):576. doi: 10.3390/brainsci15060576.
4
Translational network neuroscience: Nine roadblocks and possible solutions.转化神经科学网络:九个障碍及可能的解决方案。
Netw Neurosci. 2025 Mar 20;9(1):352-370. doi: 10.1162/netn_a_00435. eCollection 2025.
5
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.贝伐单抗治疗复发性胶质母细胞瘤:剂量重要吗?我们的单中心比较经验。
J Neurooncol. 2025 Jun;173(2):449-456. doi: 10.1007/s11060-025-04992-4. Epub 2025 Mar 10.
6
Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps.扩散与灌注磁共振成像与源自放射组学图谱的胶质瘤特征相关性的多中心回顾性分析
Neuro Oncol. 2025 Feb 17. doi: 10.1093/neuonc/noaf044.
7
Glioma-white matter tract interactions: A diffusion magnetic resonance imaging-based 3-tier classification and its clinical relevance.胶质瘤与白质束的相互作用:基于扩散磁共振成像的三级分类及其临床相关性。
Neuro Oncol. 2025 Sep 8;27(7):1888-1898. doi: 10.1093/neuonc/noaf036.
8
Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?脑网络连通性能否促进疾病修饰性抗阿尔茨海默病药物的临床开发?
Brain Commun. 2024 Dec 18;7(1):fcae460. doi: 10.1093/braincomms/fcae460. eCollection 2025.
9
Relationship between glioblastoma location and O-methylguanine-DNA methyltransferase promoter methylation percentage.胶质母细胞瘤位置与O-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化百分比之间的关系。
Brain Commun. 2024 Dec 3;6(6):fcae415. doi: 10.1093/braincomms/fcae415. eCollection 2024.
10
Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review.使用磁共振扩散张量成像预测胶质母细胞瘤进展:一项系统综述。
J Neuroimaging. 2025 Jan-Feb;35(1):e13251. doi: 10.1111/jon.13251.